SEARCH
Home
News
Fortune 500
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Great Place to Work
Tech
AI
Innovation
Cybersecurity
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Success
Future of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Analytics
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Home
News
FORTUNE 500
FORTUNE 500
FORTUNE SEA 500
Fortune 500 Europe
Fortune Global 500
Fortune China 500
Great Place to Work
Tech
Tech
AI
Innovation
Cybersecurity
Finance
Finance
Personal Finance
Real Estate
Economy
Banking
Investing
Crypto
Leadership
Leadership
Success
Future of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Rankings
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Asia
Europe
Analytics
David Z. Morris
Stay informed with David Z. Morris’s coverage and analysis for Fortune.
Newsletters
The last mile of the immunization campaign approaches
By
Sy Mukherjee
and
David Z. Morris
Politics
COVID exposed global supply-chain flaws. Can Biden bring manufacturing back to the U.S.?
By
David Z. Morris
Newsletters
Skeptical of outdoor masking? Congratulations on catching up to reality.
By
Sy Mukherjee
and
David Z. Morris
Newsletters
The last mile of the immunization campaign approaches
By
Sy Mukherjee
and
David Z. Morris
Newsletters
Is the Bitcoin bull run over?
By
David Z. Morris
and
Robert Hackett
Newsletters
What’s the matter with Michigan?
By
Sy Mukherjee
and
David Z. Morris
Newsletters
A milestone for COVID vaccinations as all U.S. adults are eligible
By
Sy Mukherjee
and
David Z. Morris
Newsletters
What makes a drug company truly innovative?
By
Sy Mukherjee
and
David Z. Morris
Newsletters
Johnson & Johnson: The pause heard ’round the world
By
David Z. Morris
and
Sy Mukherjee
Newsletters
The crucial third party players in the pandemic fight
By
David Z. Morris
and
Sy Mukherjee
Newsletters
Maybe Coinbase is hard to value because it’s a ‘hyperobject’
By
David Z. Morris
and
Robert Hackett
Newsletters
An abundance of caution with the Johnson & Johnson vaccine
By
David Z. Morris
and
Sy Mukherjee
Health
You just got the J&J COVID vaccine. Should you be worried about the CDC’s pause recommendation?
By
David Z. Morris
The Coins
Mastercard, UBS, and JPMorgan pour $65 million into Ethereum startup studio ConsenSys
By
David Z. Morris
Newsletters
The public health scourge we don’t talk about nearly enough
By
David Z. Morris
and
Sy Mukherjee